Skip to main content

Normal Non-fluency

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Nidek
NidekJapan - Aichi
1 program
Comparative Study of the Optical Biometer for Measurements of the EyeN/A1 trial
Active Trials
NCT01729962Completed125Est. May 2013

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
NidekComparative Study of the Optical Biometer for Measurements of the Eye

Clinical Trials (1)

Total enrollment: 125 patients across 1 trials

NCT01729962NidekComparative Study of the Optical Biometer for Measurements of the Eye

Comparative Study of the Optical Biometer for Measurements of the Eye

Start: Dec 2012Est. completion: May 2013125 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.